Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity.
Lassailly G, Caiazzo R, Hollebecque A, Buob D, Leteurtre E, Arnalsteen L, Louvet A, Pigeyre M, Raverdy V, Verkindt H, Six MF, Eberle C, Patrice A, Dharancy S, Romon M, Pattou F, Mathurin P.
Lassailly G, et al. Among authors: caiazzo r.
Eur J Gastroenterol Hepatol. 2011 Jun;23(6):499-506. doi: 10.1097/MEG.0b013e3283464111.
Eur J Gastroenterol Hepatol. 2011.
PMID: 21499110